Budding uninhibited by benzimidazoles 1 (BUB1B), a mitotic checkpoint serine/threonine kinase, that serves an important role in chromosome alignment, has been shown to act as a tumor promoter in many cancers (10–12). Here, MARK2 is linked to cancer.